BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37954562)

  • 1. Genetic testing in the management of inherited cardiac disorders: two cases of Filamin-C arrhythmogenic left ventricular cardiomyopathy.
    Abela M; Grech N; Debattista J; Felice T
    Eur Heart J Case Rep; 2023 Nov; 7(11):ytad515. PubMed ID: 37954562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac arrest as first presentation of arrhythmogenic left ventricular cardiomyopathy due to Filamin C mutation: a case report.
    Kandhari N; Khoury S; Behr ER; Miles C
    Eur Heart J Case Rep; 2021 Nov; 5(11):ytab422. PubMed ID: 34993393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left-dominant arrhythmogenic cardiomyopathy: an association with desmoglein-2 gene mutation-a case report.
    Lao N; Laiq Z; Courson J; Al-Quthami A
    Eur Heart J Case Rep; 2021 Jun; 5(6):ytab213. PubMed ID: 34263121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death.
    Celeghin R; Cipriani A; Bariani R; Bueno Marinas M; Cason M; Bevilacqua M; De Gaspari M; Rizzo S; Rigato I; Da Pozzo S; Zorzi A; Perazzolo Marra M; Thiene G; Iliceto S; Basso C; Corrado D; Pilichou K; Bauce B
    Heart Rhythm; 2022 Feb; 19(2):235-243. PubMed ID: 34601126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case series of desmoplakin cardiomyopathy: a mimic of viral myocarditis.
    Rezaei Bookani K; Minga I; Wodskow J; Harris J; Gordon R; Sarswat N; Pursnani A
    Eur Heart J Case Rep; 2022 Aug; 6(8):ytac341. PubMed ID: 36043215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
    Zhang N; Song Y; Hua W; Hu Y; Chen L; Cai M; Niu H; Cai C; Gu M; Zhao S; Zhang S
    Int J Cardiol; 2021 Aug; 337():79-85. PubMed ID: 33839174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings.
    Casella M; Gasperetti A; Sicuso R; Conte E; Catto V; Sommariva E; Bergonti M; Vettor G; Rizzo S; Pompilio G; Andreini D; Saguner AM; Duru F; Natale A; Thiene G; Basso C; Dello Russo A; Tondo C
    Circ Arrhythm Electrophysiol; 2020 Dec; 13(12):e009005. PubMed ID: 33197325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scarring/arrhythmogenic cardiomyopathy.
    Corrado D; Zorzi A; Cipriani A; Bauce B; Bariani R; Brunetti G; Graziano F; De Lazzari M; Mattesi G; Migliore F; Pilichou K; Rigato I; Rizzo S; Thiene G; Perazzolo Marra M; Basso C
    Eur Heart J Suppl; 2023 May; 25(Suppl C):C144-C154. PubMed ID: 37125320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LV-predominant arrhythmogenic cardiomyopathy related to pathogenic DSP-variant.
    Ahmad S; El Sharu H; Fernandes R; Kolasa M; Bogdan Marcu C
    Clin Case Rep; 2024 Jun; 12(6):e9003. PubMed ID: 38827944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmogenic Left Ventricular Cardiomyopathy: From Diagnosis to Risk Management.
    Mauriello A; Roma AS; Ascrizzi A; Molinari R; Loffredo FS; D'Andrea A; Russo V
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: DSP truncation variant p. R1951X leads to arrhythmogenic left ventricular cardiomyopathy.
    Chen V; Knight BP; McNally EM
    Eur Heart J Case Rep; 2022 Mar; 6(3):ytac105. PubMed ID: 35474678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Bosman LP; Te Riele ASJM
    Heart; 2022 Jan; 108(2):90-97. PubMed ID: 33990412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?
    Bennett RG; Haqqani HM; Berruezo A; Della Bella P; Marchlinski FE; Hsu CJ; Kumar S
    Heart Lung Circ; 2019 Jan; 28(1):164-177. PubMed ID: 30446243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy.
    Monda E; Rubino M; Palmiero G; Verrillo F; Lioncino M; Diana G; Cirillo A; Fusco A; Dongiglio F; Caiazza M; Altobelli I; Mauriello A; Guarnaccia N; Scatteia A; Cesaro A; Pacileo G; Sarubbi B; Frisso G; Bauce B; D'Andrea A; Dellegrottaglie S; Russo MG; Calabrò P; Limongelli G
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated JUP plakoglobin gene mutation with left ventricular fibrosis in familial arrhythmogenic right ventricular cardiomyopathy.
    Zinkovsky D; Sood MR
    J Cardiovasc Electrophysiol; 2023 Oct; 34(10):2112-2121. PubMed ID: 37717241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report.
    Corrado D; Anastasakis A; Basso C; Bauce B; Blomström-Lundqvist C; Bucciarelli-Ducci C; Cipriani A; De Asmundis C; Gandjbakhch E; Jiménez-Jáimez J; Kharlap M; McKenna WJ; Monserrat L; Moon J; Pantazis A; Pelliccia A; Perazzolo Marra M; Pillichou K; Schulz-Menger J; Jurcut R; Seferovic P; Sharma S; Tfelt-Hansen J; Thiene G; Wichter T; Wilde A; Zorzi A
    Int J Cardiol; 2024 Jan; 395():131447. PubMed ID: 37844667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.
    Augusto JB; Eiros R; Nakou E; Moura-Ferreira S; Treibel TA; Captur G; Akhtar MM; Protonotarios A; Gossios TD; Savvatis K; Syrris P; Mohiddin S; Moon JC; Elliott PM; Lopes LR
    Eur Heart J Cardiovasc Imaging; 2020 Mar; 21(3):326-336. PubMed ID: 31317183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
    Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
    Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cardiac magnetic resonance in the differential diagnosis between arrhythmogenic cardiomyopathy with left ventricular involvement and previous infectious myocarditis.
    Colombo D; Turco A; Lomi S; Valentini A; Bassi E; Scelsi L; Greco A; Schirinzi S; Zacchino M; Acquaro M; Oliveri F; Preda L; Ghio S
    Int J Cardiol; 2023 Mar; 374():120-126. PubMed ID: 36535562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.
    Bariani R; Rigato I; Celeghin R; Marinas MB; Cipriani A; Zorzi A; Pergola V; Iliceto S; Basso C; Marra MP; Corrado D; Gregori D; Pilichou K; Bauce B
    J Am Coll Cardiol; 2024 Feb; 83(8):797-807. PubMed ID: 38383094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.